CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.

Clinical trial NCT06733610 · RECRUITING

Trial details

NCT number: NCT06733610
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Hemolytic Anemia CD19/BCMA CAR T-cells Universal Allogeneic CAR T-cells

Start date: 2024-12-05
Primary completion: 2026-02-05
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.